Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This is a phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate to severe active ulcerative colitis.
Epistemonikos ID: 99d104063443b70c7c640aa5a0801f3f3ce62cf8
First added on: Mar 23, 2022